AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33060496 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery along with breathing relaxation
Number of subjects: 90
Study 33687633 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent behavioral intervention (SHARE project)
Number of subjects: 0
Study 33687633 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing calls
Number of subjects: 0
Study 33687633 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention exposure
Number of subjects: 0
Study 33687633 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner support
Number of subjects: 0
Study 33190860 — intervention group
Group type: EXPERIMENTAL
Intervention: SuperSeal desensitizer with shockwave (Group 2)
Number of subjects: 20
Study 33190860 — intervention group
Group type: COMPARATOR
Intervention: SuperSeal desensitizer only (Group 1)
Number of subjects: 20
Study 35664552 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized patient case simulation
Number of subjects: 286
Study 33758069 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed prognostication scores calculated on day 4 (oICH, MICH, max-ICH)
Number of subjects: 276
Study 33758069 — intervention group
Group type: COMPARATOR
Intervention: Baseline prognostication scores (oICH, MICH, max-ICH)
Number of subjects: 276
Study 32415824 — intervention group
Group type: EXPERIMENTAL
Intervention: Yogic visual concentration (Trataka)
Number of subjects: 0
Study 32415824 — intervention group
Group type: COMPARATOR
Intervention: Routine activities (Control)
Number of subjects: 0
Study 35533876 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-year home-based gardening intervention, individually mentored by extension-certified master gardeners
Number of subjects: 381
Study 35533876 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 381
Study 32851876 — intervention group
Group type: EXPERIMENTAL
Intervention: BUP-NX (sublingual buprenorphine-naloxone)
Number of subjects: 334
Study 32851876 — intervention group
Group type: COMPARATOR
Intervention: XR-NTX (extended-release injection naltrexone)
Number of subjects: 334
Study 36004376 — intervention group
Group type: EXPERIMENTAL
Intervention: Remimazolam
Number of subjects: 100
Study 32646362 — intervention group
Group type: EXPERIMENTAL
Intervention: Symbiter-Smectite
Number of subjects: 55
Study 32646362 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 35110415 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide plus mifepristone
Number of subjects: 106
Study 35110415 — intervention group
Group type: COMPARATOR
Intervention: Enzalutamide alone
Number of subjects: 106
Study 33453783 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced hybrid closed-loop system
Number of subjects: 113
Study 33453783 — intervention group
Group type: COMPARATOR
Intervention: MiniMed 670G hybrid closed-loop system
Number of subjects: 113
Study 36314399 — intervention group
Group type: EXPERIMENTAL
Intervention: Propped/prone positioning
Number of subjects: 68
Study 36314399 — intervention group
Group type: COMPARATOR
Intervention: Feed-rate intervention (continuous pump feeds)
Number of subjects: 68
Study 36200798 — intervention group
Group type: COMPARATOR
Intervention: Minority patients (Black, Asian, Hispanic)
Number of subjects: 465
Study 32680781 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephonic motivational interviewing (MoI) intervention
Number of subjects: 456
Study 32680781 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 456
Study 34761530 — intervention group
Group type: EXPERIMENTAL
Intervention: Information sheets given to participants with diabetes and their spouses (dyad group)
Number of subjects: 133
Study 34761530 — intervention group
Group type: COMPARATOR
Intervention: Information sheet given only to participants with diabetes (individual group)
Number of subjects: 133
Study 34619894 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate rehabilitation by using implant-supported full-arch prostheses (TG)
Number of subjects: 104
Study 34619894 — intervention group
Group type: COMPARATOR
Intervention: Immediate rehabilitation of implant-supported full-arch prostheses (CG)
Number of subjects: 104
Study 33497854 — intervention group
Group type: EXPERIMENTAL
Intervention: Online hazard perception training course
Number of subjects: 0
Study 33497854 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 34146512 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone (0.8 mg/day sustained release)
Number of subjects: 3494
Study 34146512 — intervention group
Group type: COMPARATOR
Intervention: Placebo (high risk)
Number of subjects: 3494
Study 34146512 — intervention group
Group type: COMPARATOR
Intervention: Placebo (low risk)
Number of subjects: 3494
Study 34146512 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone (high risk)
Number of subjects: 3494
Study 33271893 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating habits and dietary practices among students
Number of subjects: 564
Study 33271893 — intervention group
Group type: EXPERIMENTAL
Intervention: Barriers to adherence to healthy eating
Number of subjects: 564
Study 33271893 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness of healthy diets
Number of subjects: 564
Study 35606100 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose methotrexate (LD-MTX)
Number of subjects: 20
Study 35606100 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 34606758 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet administration of FAMCAT
Number of subjects: 300
Study 34606758 — intervention group
Group type: COMPARATOR
Intervention: Interview administration of FAMCAT
Number of subjects: 300
Study 33063308 — intervention group
Group type: EXPERIMENTAL
Intervention: Creative Strengthening Groups
Number of subjects: 366
Study 33063308 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 366
Study 34988564 — intervention group
Group type: EXPERIMENTAL
Intervention: Riceberry rice beverage (RRB) with HCMF meal (2 g of riceberry rice extract powder/400 ml)
Number of subjects: 13
Study 34988564 — intervention group
Group type: EXPERIMENTAL
Intervention: Riceberry rice beverage (RRB) with HCMF meal
Number of subjects: 13
Study 34988564 — intervention group
Group type: COMPARATOR
Intervention: HCMF meal without RRB
Number of subjects: 13
Study 34988564 — intervention group
Group type: COMPARATOR
Intervention: HCMF meal with or without RRB
Number of subjects: 13
Study 33788326 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete harm reduction program (HRP) participation (≥ 60 mg/day methadone and 100% needle and syringe program coverage)
Number of subjects: 983
Study 33788326 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete harm reduction program (HRP) participation
Number of subjects: 983
Study 33788326 — intervention group
Group type: COMPARATOR
Intervention: No HRP and partial HRP participation (< 60 mg/day methadone and/or < 100% NSP coverage)
Number of subjects: 983
Study 32381925 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine oral supplements (group C)
Number of subjects: 1
Study 32381925 — intervention group
Group type: COMPARATOR
Intervention: No L-carnitine oral supplements (group N)
Number of subjects: 1
Study 36384737 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone 40 mg once daily for 10 days
Number of subjects: 115
Study 36384737 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study 36384737 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone and Placebo (both groups performed olfactory training)
Number of subjects: 115
Study 36384737 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone and Placebo
Number of subjects: 115
Study 32164675 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate/formoterol fumarate (GFF)
Number of subjects: 1943
Study 36409058 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium chloride (1 g/d) as an add-on to lithium carbonate
Number of subjects: 60
Study 36409058 — intervention group
Group type: COMPARATOR
Intervention: Lithium carbonate with advice not to take additional salt
Number of subjects: 60
Study 34459406 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted coffee consumption (cups/day)
Number of subjects: 447516
Study 34459406 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted 50% increase of coffee consumption
Number of subjects: 447516
Study 32839028 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipragliflozin
Number of subjects: 70
Study 32839028 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation from previously established FPG model
Number of subjects: 70
Study 33301740 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course radiotherapy (5 × 5 Gy over a maximum of 8 days) followed by six cycles of CAPOX chemotherapy or nine cycles of FOLFOX4, followed by total mesorectal excision.
Number of subjects: 912
Study 33301740 — intervention group
Group type: COMPARATOR
Intervention: Standard of care: 28 daily fractions of 1.8 Gy up to 50.4 Gy or 25 fractions of 2.0 Gy up to 50.0 Gy with concomitant capecitabine 825 mg/m2, followed by total mesorectal excision and optional adjuvant chemotherapy.
Number of subjects: 912
Study 33301740 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 912
Study 33301740 — intervention group
Group type: COMPARATOR
Intervention: Standard of care group
Number of subjects: 912
Study 32918486 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 0
Study 32918486 — intervention group
Group type: COMPARATOR
Intervention: Gliclazide
Number of subjects: 0
Study 35727393 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser at 500 mJ and 15 Hz
Number of subjects: 30
Study 35727393 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser at 300 mJ and 15 Hz
Number of subjects: 30
Study 35727393 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser at 400 mJ and 15 Hz
Number of subjects: 30
Study 35727393 — intervention group
Group type: EXPERIMENTAL
Intervention: 9.6% hydrofluoric acid
Number of subjects: 30
Study 35727393 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 30
Study 34254189 — intervention group
Group type: EXPERIMENTAL
Intervention: Insoluble oat hulls fibre supplement
Number of subjects: 180
Study 34254189 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplement
Number of subjects: 180
Study 32532035 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 PUFAs enriched hen eggs (1053 mg n-3 PUFAs/day)
Number of subjects: 38
Study 32532035 — intervention group
Group type: COMPARATOR
Intervention: Regular hen eggs (249 mg n-3 PUFAs/day)
Number of subjects: 38
Study 36069928 — intervention group
Group type: EXPERIMENTAL
Intervention: Bihormonal artificial pancreas (BIHAP)
Number of subjects: 12
Study 36069928 — intervention group
Group type: COMPARATOR
Intervention: Current diabetes care (insulin pump or pen therapy)
Number of subjects: 12
Study 33963722 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 μg · kg‐1·h‐1 DEX
Number of subjects: 120
Study 33963722 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 μg · kg‐1·h‐1 DEX
Number of subjects: 120
Study 33963722 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.8 μg · kg‐1·h‐1 DEX
Number of subjects: 120
Study 33963722 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 120
Study 36238824 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed reduction and internal fixation with hollow nails
Number of subjects: 90
Study 36238824 — intervention group
Group type: COMPARATOR
Intervention: Open reduction and internal fixation with hollow nails
Number of subjects: 90
Study 32072269 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin (BT)
Number of subjects: 0
Study 33025006 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm rice (14 mg · kg‐1 · d‐1)
Number of subjects: 6
Study 33025006 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold rice (14 mg · kg‐1 · d‐1)
Number of subjects: 6
Study 35905573 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone Hexacetonide + Lidocaine (TH/LD)
Number of subjects: 60
Study 35905573 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine (LD)
Number of subjects: 60
Study 32758058 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucine (1.11 g) + Resveratrol (50 mg)
Number of subjects: 36
Study 32758058 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 35822931 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific Task and Splint Group
Number of subjects: 33
Study 35822931 — intervention group
Group type: COMPARATOR
Intervention: Comparison Group
Number of subjects: 33
Study 33303111 — intervention group
Group type: EXPERIMENTAL
Intervention: PFO closure
Number of subjects: 591
Study 33303111 — intervention group
Group type: EXPERIMENTAL
Intervention: PFO closure (in thrombophilia subgroup)
Number of subjects: 591
Study 33303111 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy (in thrombophilia subgroup)
Number of subjects: 591
Study 33303111 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombophilia
Number of subjects: 591
Study 35587070 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine and propolis (NACp) 600 mg
Number of subjects: 120
Study 35587070 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine and propolis (NACp) 1200 mg
Number of subjects: 120
Study 35587070 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 33848070 — intervention group
Group type: EXPERIMENTAL
Intervention: Parasacral TENS administered twice weekly
Number of subjects: 34
Study 33848070 — intervention group
Group type: EXPERIMENTAL
Intervention: Parasacral TENS administered three times weekly
Number of subjects: 34
Study 33848070 — intervention group
Group type: EXPERIMENTAL
Intervention: Bladder diary evaluation for both groups
Number of subjects: 34
Study 34147954 — intervention group
Group type: EXPERIMENTAL
Intervention: SCM stretching and massage
Number of subjects: 60
Study 34147954 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy (CG)
Number of subjects: 60
Study 35431898 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory-Cognitive Training (AC training; n = 13)
Number of subjects: 50
Study 35431898 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory Training (A training; n = 13)
Number of subjects: 50
Study 35431898 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Training (C training; n = 14)
Number of subjects: 50
Study 35431898 — intervention group
Group type: COMPARATOR
Intervention: Active Control (n = 12)
Number of subjects: 50
Study 33019888 — intervention group
Group type: COMPARATOR
Intervention: Usual care (direct usual care aphasia therapy)
Number of subjects: 246
Study 33019888 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity group (usual care-plus or prescribed direct aphasia therapy)
Number of subjects: 246
Study 35409964 — intervention group
Group type: EXPERIMENTAL
Intervention: EMPWR intervention
Number of subjects: 301
Study 33771104 — intervention group
Group type: EXPERIMENTAL
Intervention: Baroreflex activation therapy plus guideline directed therapy (BAT + GDT)
Number of subjects: 0
Study 33771104 — intervention group
Group type: COMPARATOR
Intervention: Guideline directed therapy (GDT) alone
Number of subjects: 0
Study 32252739 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized coaching for 18 months (n=186)
Number of subjects: 380
Study 32252739 — intervention group
Group type: COMPARATOR
Intervention: Standard care (n=194)
Number of subjects: 380
Study 32252739 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized coaching
Number of subjects: 380
Study 32252739 — intervention group
Group type: COMPARATOR
Intervention: Individualized coaching and Standard care
Number of subjects: 380
Study 36304830 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar-free apricot jam with white bread (JWB)
Number of subjects: 12
Study 36304830 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocoa with fat-free milk (CM)
Number of subjects: 12
Study 36304830 — intervention group
Group type: EXPERIMENTAL
Intervention: Dried cranberry cereal bar (CB)
Number of subjects: 12
Study 36304830 — intervention group
Group type: EXPERIMENTAL
Intervention: White bread (WB)
Number of subjects: 12
Study 36304830 — intervention group
Group type: COMPARATOR
Intervention: d-glucose
Number of subjects: 12
Study 35370914 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimized acupuncture and moxibustion treatment (OAMT), given five times per week for 4 weeks.
Number of subjects: 134
Study 35370914 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 134
Study 35779599 — intervention group
Group type: EXPERIMENTAL
Intervention: Leaflet resection strategy
Number of subjects: 104
Study 35779599 — intervention group
Group type: COMPARATOR
Intervention: Leaflet preservation strategy
Number of subjects: 104
Study 35779599 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated gradients
Number of subjects: 104
Study 36329513 — intervention group
Group type: EXPERIMENTAL
Intervention: Treamid 50 mg once a day for 4 weeks
Number of subjects: 59
Study 36329513 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 32927285 — intervention group
Group type: EXPERIMENTAL
Intervention: Apomorphine sublingual film (APL) titration (10–35 mg)
Number of subjects: 141
Study 32927285 — intervention group
Group type: EXPERIMENTAL
Intervention: Apomorphine sublingual film (APL)
Number of subjects: 141
Study 32927285 — intervention group
Group type: COMPARATOR
Intervention: Carbidopa/levodopa (CD/LD)
Number of subjects: 141
Study 36279409 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine at a starting rate of 0.05 μg·kg‐1·min‐1 (n = 62)
Number of subjects: 124
Study 36279409 — intervention group
Group type: COMPARATOR
Intervention: Phenylephrine at a starting rate of 0.5 μg·kg‐1·min‐1 (n = 62)
Number of subjects: 124
Study 36279409 — intervention group
Group type: COMPARATOR
Intervention: Phenylephrine group
Number of subjects: 124
Study 36279409 — intervention group
Group type: COMPARATOR
Intervention: Phenylephrine group (excluding parturients with gestational diabetes)
Number of subjects: 124
Study 33646860 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketone monoester (KE) supplement (600 mg/kg body mass)
Number of subjects: 19
Study 33646860 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 32763450 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced steering system
Number of subjects: 14
Study 32763450 — intervention group
Group type: COMPARATOR
Intervention: Conventional steering system
Number of subjects: 14
Study 33128085 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunohistochemical panel (eight antibodies)
Number of subjects: 187
Study 32868483 — intervention group
Group type: EXPERIMENTAL
Intervention: IPACK block
Number of subjects: 119
Study 32868483 — intervention group
Group type: COMPARATOR
Intervention: Sham block
Number of subjects: 119
Study 35697592 — intervention group
Group type: EXPERIMENTAL
Intervention: Infrared filter film with 75% visible light transmission and 90% infrared rejection
Number of subjects: 44
Study 35697592 — intervention group
Group type: COMPARATOR
Intervention: Control group (no infrared filter film)
Number of subjects: 44
Study 35697592 — intervention group
Group type: EXPERIMENTAL
Intervention: Infrared filter film
Number of subjects: 44
Study 35752716 — intervention group
Group type: EXPERIMENTAL
Intervention: Phacoviscocanalostomy (n = 45)
Number of subjects: 89
Study 35752716 — intervention group
Group type: COMPARATOR
Intervention: Phacoemulsification alone (n = 44)
Number of subjects: 89
Study 34404294 — intervention group
Group type: EXPERIMENTAL
Intervention: Elite players
Number of subjects: 68
Study 34404294 — intervention group
Group type: COMPARATOR
Intervention: Low-division players
Number of subjects: 68
Study 33024990 — intervention group
Group type: EXPERIMENTAL
Intervention: 9.3 wt% protein concentration milk
Number of subjects: 12
Study 33024990 — intervention group
Group type: COMPARATOR
Intervention: 3.1 wt% protein concentration milk
Number of subjects: 12
Study 33024990 — intervention group
Group type: EXPERIMENTAL
Intervention: 40:60 casein to whey ratio milk
Number of subjects: 12
Study 33024990 — intervention group
Group type: COMPARATOR
Intervention: 80:20 casein to whey ratio milk
Number of subjects: 12
Study 33024990 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments pooled
Number of subjects: 12
Study 33024990 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-lunch BG
Number of subjects: 12
Study 33024990 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-lunch BG
Number of subjects: 12
Study 35075216 — intervention group
Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 99
Study 32920022 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg of enteric-coated aspirin daily
Number of subjects: 4758
Study 32920022 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 4758
Study 34244805 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity treadmill exercise
Number of subjects: 110
Study 34244805 — intervention group
Group type: COMPARATOR
Intervention: Moderate-intensity treadmill exercise
Number of subjects: 110
Study 34244805 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 110
Study 32497586 — intervention group
Group type: COMPARATOR
Intervention: Interval Running (IR)
Number of subjects: 232
Study 32497586 — intervention group
Group type: COMPARATOR
Intervention: Small-Sided Games (SSG)
Number of subjects: 232
Study 33907782 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-dimensional oral cleaning intervention model
Number of subjects: 600
Study 33907782 — intervention group
Group type: COMPARATOR
Intervention: Routine oral health education (Control)
Number of subjects: 600
Study 33899509 — intervention group
Group type: EXPERIMENTAL
Intervention: QFR ≤0.80
Number of subjects: 617
Study 33899509 — intervention group
Group type: COMPARATOR
Intervention: QFR >0.80
Number of subjects: 617
Study 35437114 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery (MIS)
Number of subjects: 0
Study 33388951 — intervention group
Group type: EXPERIMENTAL
Intervention: Glasdegib (100 mg, oral, fasted conditions)
Number of subjects: 18
Study 32981242 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacillus isolate B-27
Number of subjects: 0
Study 35493937 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal-tDCS (atDCS) + Working Memory Training (WMT)
Number of subjects: 54